NCT03136796View on ClinicalTrials.gov

Glycocalyx Damage and Beta-lactam Antibiotics in Surgical Critically Ill

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

May 2, 2017

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Critical Illness
Interventions
DRUG

Meropenem

Patients will receive intravenous antibiotics eighter empirically or based on a culture.

Trial Locations (1)

50005

University Hospital Hradec Kralove, Hradec Králové

All Listed Sponsors
lead

University Hospital Hradec Kralove

OTHER

NCT03136796 - Glycocalyx Damage and Beta-lactam Antibiotics in Surgical Critically Ill | Biotech Hunter | Biotech Hunter